组织型纤溶酶原激活剂给药后引起气道受压的咽后血肿：一例报告
Retropharyngeal Hematoma Causing Airway Compromise After Tissue Plasminogen Activator Administration: A Case Report.
作者信息
Provenza Christian, Habermann Arun Christian, Williams Theron, Metter Jeffrey, Walker James Richard
机构信息
University of Tennessee Health Science Center - Department of Emergency Medicine, Memphis, Tennessee.
University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee.
出版信息
Clin Pract Cases Emerg Med. 2023 Aug;7(3):168-171. doi: 10.5811/cpcem.1602.
INTRODUCTION
Tissue plasminogen activator (tPA), commonly used for treatment of acute ischemic stroke, is associated with life-threatening bleeding intracranially as well as surrounding the airway.
CASE REPORT
A 78-year-old year old male who presented with stroke symptoms and after tPA administration developed a retropharyngeal hematoma requiring intubation and surgical intervention.
CONCLUSION
Numerous threats to the patient's airway can develop after tPA administration. While angioedema is the most common cause, it is important to be prepared for other causes related to hemorrhage.
引言
组织型纤溶酶原激活剂（tPA）常用于治疗急性缺血性中风，但其与颅内及气道周围危及生命的出血有关。
病例报告
一名78岁男性出现中风症状，在使用tPA后发生咽后血肿，需要插管和手术干预。
结论
使用tPA后可能会出现多种危及患者气道的情况。虽然血管性水肿是最常见的原因，但对其他与出血相关的原因做好准备也很重要。
Zotero 插件